Fig. 4From: Radiotherapy-induced anti-tumor immune response and immune-related adverse events in a case of recurrent nasopharyngeal carcinoma undergoing anti-PD-1 immunotherapyTreatment plan for stereotactic re-re-irradiation using rotational intensity-modulated radiotherapy (volumetric modulated arc therapy; VMAT). The 95%-isodose coverage of the prescribed 45Â Gy is shown on fused MRI in axial and sagittal plane, with the latter demonstrating extensive craniocaudal (including prevertebral) tumor extensionBack to article page